Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 98 publications
124I-Evuzamitide Positron Emission Tomography/Computed Tomography for Diagnosing Cardiac Amyloidosis: The REVEAL Nonrandomized Clinical Trial.
Journal: JAMA
Published: August 30, 2026
Effect of Acoramidis on Heart Failure-Related Health Status: A Secondary Analysis of the ATTRibute-CM Randomized Clinical Trial.
Journal: JAMA cardiology
Published: July 29, 2026
Diagnostic Trends and Geographic Health Care Disparities Among Patients With Transthyretin Amyloid Cardiomyopathy.
Journal: Journal of the American Heart Association
Published: June 09, 2026
Correction: CPX-351 vs. conventional chemotherapy cardiotoxicity in high-risk AML: a post hoc phase III trial analysis.
Journal: Cardio-oncology (London, England)
Published: May 23, 2026
Design and rationale of the Research with EVuzamitide to Evaluate for cardiac AmyLoidosis (REVEAL) positron emission tomography study: A study of 124I-evuzamitide to diagnose cardiac amyloidosis.
Journal: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Published: May 21, 2026
Cluster Randomized Controlled Trial of Intensive Systolic Blood Pressure Control in Patients With Renal Cell or Thyroid Cancer Receiving VEGFR Tyrosine Kinase Inhibitors: ECOG-ACRIN EAQ191.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: May 20, 2026
When Off-Label Ketamine Meets Direct-to-Consumer Telehealth: Liability Risks and Ethical Responsibilities.
Journal: Psychiatric services (Washington, D.C.)
Published: May 20, 2026
A National Survey of VA to Assess Availability of Care for Patients With Cardiac Amyloidosis.
Journal: JACC. Advances
Published: March 24, 2026
Long-Term Stability of a Coronary-Encasing Cardiac Paraganglioma: A 4-Year Multimodality Imaging Follow-Up.
Journal: Circulation. Cardiovascular imaging
Published: February 26, 2026
Heart Substructure Radiation Dose and Cardiac Outcomes: Contemporary Evidence and Actionable Opportunities: JACC CardioOncology State-of-the-Art Review.
Journal: JACC. CardioOncology
Published: February 16, 2026
Bio-Adrenomedullin Predicts Death and Major Adverse Cardiovascular Events in Cardiac Amyloidosis: A Cross-Continental Multicenter Study.
Journal: Journal of the American Heart Association
Published: December 23, 2025
Acoramidis, Serum Transthyretin, and Cardiovascular Outcomes in Transthyretin Amyloid Cardiomyopathy: Insights From the ATTRibute-CM Trial.
Journal: Journal of cardiac failure
Published: November 26, 2025
Last Updated: 09/26/2026